A Genome-wide Short Hairpin RNA Screening of Jurkat T-cells for Human Proteins Contributing to Productive HIV-1 Replication*

Short interfering RNAs (siRNAs) have been used to inhibit HIV-1 replication. The durable inhibition of HIV-1 replication by RNA interference has been impeded, however, by a high mutation rate when viral sequences are targeted and by cytotoxicity when cellular genes are knocked down. To identify cellular proteins that contribute to HIV-1 replication that can be chronically silenced without significant cytotoxicity, we employed a shRNA library that targets 54,509 human transcripts. We used this library to select a comprehensive population of Jurkat T-cell clones, each expressing a single discrete shRNA. The Jurkat clones were then infected with HIV-1. Clones that survived viral infection represent moieties silenced for a human mRNA needed for virus replication, but whose chronic knockdown did not cause cytotoxicity. Overall, 252 individual Jurkat mRNAs were identified. Twenty-two of these mRNAs were secondarily verified for their contributions to HIV-1 replication. Five mRNAs, NRF1, STXBP2, NCOA3, PRDM2, and EXOSC5, were studied for their effect on steps of the HIV-1 life cycle. We discuss the similarities and differences between our shRNA findings for HIV-1 using a spreading infection assay in human Jurkat T-cells and results from other investigators who used siRNA-based screenings in HeLa or 293T cells.

[1]  B. Berkhout,et al.  RISCy Business: MicroRNAs, Pathogenesis, and Viruses* , 2007, Journal of Biological Chemistry.

[2]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[3]  J. Rossi,et al.  RNA‐Mediated Inhibition of HIV in a Gene Therapy Setting , 2003, Annals of the New York Academy of Sciences.

[4]  B. Berkhout,et al.  Proteomic Studies Reveal Coordinated Changes in T-Cell Expression Patterns upon Infection with Human Immunodeficiency Virus Type 1 , 2008, Journal of Virology.

[5]  Y. Yin,et al.  PTEN: a new guardian of the genome , 2008, Oncogene.

[6]  S. Munier,et al.  Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency , 2005, Retrovirology.

[7]  E. Petfalski,et al.  Three Novel Components of the Human Exosome* , 2001, The Journal of Biological Chemistry.

[8]  Ajit Kumar.  The silent defense: Micro-RNA directed defense against HIV-1 replication , 2007, Retrovirology.

[9]  Yuki Naito,et al.  Optimal design and validation of antiviral siRNA for targeting HIV-1 , 2007, Retrovirology.

[10]  A. Fire,et al.  RNA-triggered gene silencing. , 1999, Trends in genetics : TIG.

[11]  Amy S. Espeseth,et al.  Genome-scale RNAi screen for host factors required for HIV replication. , 2008, Cell host & microbe.

[12]  Mary K. Lewinski,et al.  Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription , 2005, Journal of Virology.

[13]  A. Fauci,et al.  Short Communication HTLV Type I Tax Activation of the CXCR4 Promoter by Association with Nuclear Respiratory Factor 1 , 1999 .

[14]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[15]  Mark L. Pearson,et al.  Complete nucleotide sequence of the AIDS virus, HTLV-III , 1985, Nature.

[16]  A. Schröder,et al.  The Transcriptional Co-activator p/CIP (NCoA-3) Is Up-regulated by STAT6 and Serves as a Positive Regulator of Transcriptional Activation by STAT6* , 2004, Journal of Biological Chemistry.

[17]  S. Green.  PPAR: a mediator of peroxisome proliferator action. , 1995, Mutation research.

[18]  Robert A. Weinberg,et al.  Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.

[19]  Thomas Tuschl,et al.  siRNAs: applications in functional genomics and potential as therapeutics , 2004, Nature Reviews Drug Discovery.

[20]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[21]  S. Goff,et al.  Host factors exploited by retroviruses , 2007, Nature Reviews Microbiology.

[22]  R. König,et al.  Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication , 2008, Cell.

[23]  D. Görlich,et al.  Nuclear pore complex assembly and maintenance in POM121- and gp210-deficient cells , 2006, The Journal of cell biology.

[24]  R. Chadwick,et al.  Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. , 2001, Genes & development.

[25]  B. Ramratnam,et al.  Human Immunodeficiency Virus Type 1 Escape from RNA Interference , 2003, Journal of Virology.

[26]  Ben Berkhout,et al.  HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome , 2005, Nucleic acids research.

[27]  M. Kauppi,et al.  Munc18-2, a Functional Partner of Syntaxin 3, Controls Apical Membrane Trafficking in Epithelial Cells* , 2000, The Journal of Biological Chemistry.

[28]  M. Toborek,et al.  PPARα and PPARγ effectively protect against HIV‐induced inflammatory responses in brain endothelial cells , 2008, Journal of neurochemistry.

[29]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[30]  S. Goff,et al.  Knockdown Screens to Knockout HIV-1 , 2008, Cell.

[31]  H. Gendelman,et al.  Proteomic analyses associate cystatin B with restricted HIV-1 replication in placental macrophages. , 2008, Placenta.

[32]  S. Mahalingam,et al.  The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. , 1995, Virology.

[33]  Vicente Planelles,et al.  Host factors influencing susceptibility to HIV infection and AIDS progression , 2007, Retrovirology.

[34]  P. Earl,et al.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity , 1988, Journal of virology.

[35]  Ben Berkhout,et al.  Human Immunodeficiency Virus Type 1 Escapes from RNA Interference-Mediated Inhibition , 2004, Journal of Virology.

[36]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.